Literature DB >> 12702754

Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris.

Byung-Kwon Choi1, Piotr Bobrowicz, Robert C Davidson, Stephen R Hamilton, David H Kung, Huijuan Li, Robert G Miele, Juergen H Nett, Stefan Wildt, Tillman U Gerngross.   

Abstract

The secretory pathway of Pichia pastoris was genetically re-engineered to perform sequential glycosylation reactions that mimic early processing of N-glycans in humans and other higher mammals. After eliminating nonhuman glycosylation by deleting the initiating alpha-1,6-mannosyltransferase gene from P. pastoris, several combinatorial genetic libraries were constructed to localize active alpha-1,2-mannosidase and human beta-1,2-N-acetylglucosaminyltransferase I (GnTI) in the secretory pathway. First, >32 N-terminal leader sequences of fungal type II membrane proteins were cloned to generate a leader library. Two additional libraries encoding catalytic domains of alpha-1,2-mannosidases and GnTI from mammals, insects, amphibians, worms, and fungi were cloned to generate catalytic domain libraries. In-frame fusions of the respective leader and catalytic domain libraries resulted in several hundred chimeric fusions of fungal targeting domains and catalytic domains. Although the majority of strains transformed with the mannosidase/leader library displayed only modest in vivo [i.e., low levels of mannose (Man)(5)-(GlcNAc)(2)] activity, we were able to isolate several yeast strains that produce almost homogeneous N-glycans of the (Man)(5)-(GlcNAc)(2) type. Transformation of these strains with a UDP-GlcNAc transporter and screening of a GnTI leader fusion library allowed for the isolation of strains that produce GlcNAc-(Man)(5)-(GlcNAc)(2) in high yield. Recombinant expression of a human reporter protein in these engineered strains led to the formation of a glycoprotein with GlcNAc-(Man)(5)-(GlcNAc)(2) as the primary N-glycan. Here we report a yeast able to synthesize hybrid glycans in high yield and open the door for engineering yeast to perform complex human-like glycosylation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12702754      PMCID: PMC154291          DOI: 10.1073/pnas.0931263100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  New selectable marker/auxotrophic host strain combinations for molecular genetic manipulation of Pichia pastoris.

Authors:  G P Lin Cereghino; J Lin Cereghino; A J Sunga; M A Johnson; M Lim; M A Gleeson; J M Cregg
Journal:  Gene       Date:  2001-01-24       Impact factor: 3.688

2.  Using sorting signals to retain proteins in endoplasmic reticulum.

Authors:  H R Pelham
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

3.  Biopharmaceutical benchmarks.

Authors:  G Walsh
Journal:  Nat Biotechnol       Date:  2000-08       Impact factor: 54.908

4.  Carbohydrate compositions of the rabbit plasminogen isozymes.

Authors:  M L Hayes; R K Bretthauer; F J Castellino
Journal:  Arch Biochem Biophys       Date:  1975-12       Impact factor: 4.013

Review 5.  Heterologous protein expression in the methylotrophic yeast Pichia pastoris.

Authors:  J L Cereghino; J M Cregg
Journal:  FEMS Microbiol Rev       Date:  2000-01       Impact factor: 16.408

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  Glycosylation of Pichia pastoris-derived proteins.

Authors:  R K Bretthauer; F J Castellino
Journal:  Biotechnol Appl Biochem       Date:  1999-12       Impact factor: 2.431

Review 8.  Synthesis and processing of asparagine-linked oligosaccharides.

Authors:  S C Hubbard; R J Ivatt
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

Review 9.  Intracellular functions of N-linked glycans.

Authors:  A Helenius; M Aebi
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

10.  Use of HDEL-tagged Trichoderma reesei mannosyl oligosaccharide 1,2-alpha-D-mannosidase for N-glycan engineering in Pichia pastoris.

Authors:  N Callewaert; W Laroy; H Cadirgi; S Geysens; X Saelens; W Min Jou; R Contreras
Journal:  FEBS Lett       Date:  2001-08-17       Impact factor: 4.124

View more
  97 in total

Review 1.  Emerging technologies for making glycan-defined glycoproteins.

Authors:  Lai-Xi Wang; Joseph V Lomino
Journal:  ACS Chem Biol       Date:  2011-12-14       Impact factor: 5.100

Review 2.  Lepidopteran cells, an alternative for the production of recombinant antibodies?

Authors:  Martine Cérutti; Josée Golay
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

3.  Cell-surface expression of Aspergillus saitoi-derived functional α-1,2-mannosidase on Yarrowia lipolytica for glycan remodeling.

Authors:  Hye Yun Moon; Trinh Luu Van; Seon Ah Cheon; Jinho Choo; Jeong-Yoon Kim; Hyun Ah Kang
Journal:  J Microbiol       Date:  2013-08-30       Impact factor: 3.422

4.  Engineering of Yeast Glycoprotein Expression.

Authors:  Charlot De Wachter; Linde Van Landuyt; Nico Callewaert
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

5.  Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization.

Authors:  James M Binley; Yih-En Andrew Ban; Emma T Crooks; Dirk Eggink; Keiko Osawa; William R Schief; Rogier W Sanders
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

6.  Remodeling of the glycosylation pathway in the methylotrophic yeast Hansenula polymorpha to produce human hybrid-type N-glycans.

Authors:  Seon Ah Cheon; Hyunah Kim; Doo-Byoung Oh; Ohsuk Kwon; Hyun Ah Kang
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

Review 7.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

8.  Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.

Authors:  Sita Awasthi; John W Balliet; Jessica A Flynn; John M Lubinski; Carolyn E Shaw; Daniel J DiStefano; Michael Cai; Martha Brown; Judith F Smith; Rose Kowalski; Ryan Swoyer; Jennifer Galli; Victoria Copeland; Sandra Rios; Robert C Davidson; Maya Salnikova; Susan Kingsley; Janine Bryan; Danilo R Casimiro; Harvey M Friedman
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

Review 9.  Emerging methods for the production of homogeneous human glycoproteins.

Authors:  Jamie R Rich; Stephen G Withers
Journal:  Nat Chem Biol       Date:  2009-04       Impact factor: 15.040

10.  Paracoccin from Paracoccidioides brasiliensis; purification through affinity with chitin and identification of N-acetyl-beta-D-glucosaminidase activity.

Authors:  Fausto Bruno dos Reis Almeida; Leandro Licursi de Oliveira; Marcelo Valle de Sousa; Maria Cristina Roque Barreira; Ebert Seixas Hanna
Journal:  Yeast       Date:  2010-02       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.